EMEZENT Trademark

Trademark Overview


On Thursday, April 7, 2016, a trademark application was filed for EMEZENT with the United States Patent and Trademark Office. The USPTO has given the EMEZENT trademark a serial number of 86967871. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 28, 2018. This trademark is owned by Eli Lilly and Company. The EMEZENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
emezent

General Information


Serial Number86967871
Word MarkEMEZENT
Filing DateThursday, April 7, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 28, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Translation of Words in MarkThe word "EMEZENT" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 12, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, May 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 28, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, September 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 28, 2017EXTENSION 1 GRANTED
Thursday, September 14, 2017EXTENSION 1 FILED
Tuesday, September 26, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 14, 2017TEAS EXTENSION RECEIVED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, September 29, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 30, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 25, 2016ASSIGNED TO LIE
Tuesday, July 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 12, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, July 12, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 12, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, July 12, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, July 11, 2016ASSIGNED TO EXAMINER
Tuesday, April 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 11, 2016NEW APPLICATION ENTERED IN TRAM